These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21574647)

  • 21. Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping.
    Wulfkuhle JD; Berg D; Wolff C; Langer R; Tran K; Illi J; Espina V; Pierobon M; Deng J; DeMichele A; Walch A; Bronger H; Becker I; Waldhör C; Höfler H; Esserman L; ; Liotta LA; Becker KF; Petricoin EF
    Clin Cancer Res; 2012 Dec; 18(23):6426-35. PubMed ID: 23045247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
    Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
    BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment.
    Choi DY; You S; Jung JH; Lee JC; Rho JK; Lee KY; Freeman MR; Kim KP; Kim J
    Proteomics; 2014 Aug; 14(16):1845-56. PubMed ID: 24946052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
    Grubb RL; Deng J; Pinto PA; Mohler JL; Chinnaiyan A; Rubin M; Linehan WM; Liotta LA; Petricoin EF; Wulfkuhle JD
    J Proteome Res; 2009 Jun; 8(6):3044-54. PubMed ID: 19275204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.
    Nanjundan M; Byers LA; Carey MS; Siwak DR; Raso MG; Diao L; Wang J; Coombes KR; Roth JA; Mills GB; Wistuba II; Minna JD; Heymach JV
    J Thorac Oncol; 2010 Dec; 5(12):1894-904. PubMed ID: 21124077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation.
    Salama MF; Liu M; Clarke CJ; Espaillat MP; Haley JD; Jin T; Wang D; Obeid LM; Hannun YA
    Oncogene; 2019 Nov; 38(48):7311-7328. PubMed ID: 31420605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
    Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L
    Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR mutation status in brain metastases of non-small cell lung carcinoma.
    Burel-Vandenbos F; Ambrosetti D; Coutts M; Pedeutour F
    J Neurooncol; 2013 Jan; 111(1):1-10. PubMed ID: 23086434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.
    Sanz-Pamplona R; García-García J; Franco S; Messeguer X; Driouch K; Oliva B; Sierra A
    Mol Biosyst; 2012 Aug; 8(8):2085-96. PubMed ID: 22710377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.
    Garon EB; Finn RS; Hosmer W; Dering J; Ginther C; Adhami S; Kamranpour N; Pitts S; Desai A; Elashoff D; French T; Smith P; Slamon DJ
    Mol Cancer Ther; 2010 Jul; 9(7):1985-94. PubMed ID: 20587667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors.
    Wrona A; Dziadziuszko R; Jassem J
    Cancer Treat Rev; 2018 Dec; 71():59-67. PubMed ID: 30366200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
    Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
    Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
    Saad AG; Yeap BY; Thunnissen FB; Pinkus GS; Pinkus JL; Loda M; Sugarbaker DJ; Johnson BE; Chirieac LR
    Cancer; 2008 Oct; 113(8):2129-38. PubMed ID: 18720359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
    Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
    Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
    Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
    Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain.
    Cavallaro S
    Int J Mol Sci; 2013 Jan; 14(1):1713-27. PubMed ID: 23322021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
    Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.